Mattessich Antony C.
SEC CIK 1709900 · EDGAR
BoughtSold
Most active insiders at AURA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Matrix Capital Management Company, LP | 10% | — | $39.04M |
| 2 | de los Pinos Elisabet | See Remarks, Dir | — | $380.8K |
| 3 | Hopkins Janet Jill | Chief Medical Off | — | $196.0K |
| 4 | Plavsic Mark | CTO | — | $157.5K |
| 5 | Kilroy Conor | See Remarks | — | $143.4K |
| 6 | Gibney Anthony S | See Remarks | — | $82.3K |
| 7 | Elazzouzi Amy | SVP, Fin, PAO | — | $56.6K |
| 8 | Kratz Erica | Chief Reg, Quality Off | — | — |
| 9 | Abu-Absi Susan | COO | — | — |
| 10 | Bitetti Teresa Marie | Dir | — | — |
| 14 | Mattessich Antony C. | Dir | — | — |
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-15 16:30 | 2026-06-11 | AURA | Aura Biosciences, Inc. | Mattessich Antony C. | Dir | A - Grant | $0.00 | +15.0K | 38.5K | +64% | $0 |
| D | 2025-06-18 | 2025-06-17 | AURA | Aura Biosciences, Inc. | Mattessich Antony C. | Dir | A - Grant | $0.00 | +13.0K | 23.5K | +124% | $0 |
| D | 2024-06-24 | 2024-06-20 | AURA | Aura Biosciences, Inc. | Mattessich Antony C. | Dir | A - Grant | $0.00 | +10.5K | 10.5K | New | $0 |
| D | 2024-02-06 | 2024-02-05 | OCUL | OCULAR THERAPEUTIX, INC | Mattessich Antony C. | Pres, CEO, Dir | S - Sale | $4.86 | +19.6K | 588.7K | +3% | +$95.5K |
| D | 2024-02-06 | 2024-02-03 | OCUL | OCULAR THERAPEUTIX, INC | Mattessich Antony C. | Pres, CEO, Dir | A - Grant | $0.00 | +180.4K | 608.3K | +42% | $0 |
| 2024-02-02 | 2024-01-31 | OCUL | OCULAR THERAPEUTIX, INC | Mattessich Antony C. | Pres, CEO, Dir | S - Sale | $4.95 | -18.3K | 427.9K | -4% | -$90.8K | |
| I | 2023-09-05 | 2023-08-30 | OCUL | OCULAR THERAPEUTIX, INC | Mattessich Antony C. | Pres, CEO, Dir | P - Purchase | $3.81 | +6,500 | 6,500 | New | +$24.8K |
| 2023-02-08 | 2023-02-06 | OCUL | OCULAR THERAPEUTIX, INC | Mattessich Antony C. | Pres, CEO, Dir | S - Sale | $4.24 | -19.7K | 446.3K | -4% | -$83.4K | |
| D | 2023-02-01 | 2023-01-30 | OCUL | OCULAR THERAPEUTIX, INC | Mattessich Antony C. | Pres, CEO, Dir | A - Grant | $0.00 | +176.3K | 465.9K | +61% | $0 |
| D | 2022-02-07 | 2022-02-03 | OCUL | OCULAR THERAPEUTIX, INC | Mattessich Antony C. | Pres, CEO | A - Grant | $0.00 | +186.8K | 289.6K | +181% | $0 |
| 2021-08-24 | 2021-08-20 | OCUL | OCULAR THERAPEUTIX, INC | Mattessich Antony C. | Pres, CEO, Dir | P - Purchase | $9.89 | +5,000 | 102.9K | +5% | +$49.5K |
Purchase Sale Sale after option exercise All abbreviations